ByHeart Announces New Data Indicating that its First-of-its-Kind, U.S.-Made Infant Formula Improves Sleep Benefits in Infants, According to Clinical Trial Results
ByHeartByHeart was selected to present its industry-leading findings from its clinical trial at the American Society for Parenteral and Enteral Nutrition (ASPEN) 2023 medical conference. These findings, which show babies on ByHeart wake up less overnight to feed and sleep longer between feeds, build on ByHeart's previously announced clinically proven easy digestion and tolerance benefits published in the Journal of Pediatric Gastroenterology and Nutrition.